Balz, L.T.; Uttner, I.; Taranu, D.; Erhart, D.K.; Fangerau, T.; Jung, S.; Schreiber, H.; Senel, M.; Vardakas, I.; Lulé, D.E.;
et al. Sensitivity and Specificity of a Revised Version of the TRACK-MS Screening Battery for Early Detection of Cognitive Impairment in Patients with Multiple Sclerosis. Biomedicines 2025, 13, 1902.
https://doi.org/10.3390/biomedicines13081902
AMA Style
Balz LT, Uttner I, Taranu D, Erhart DK, Fangerau T, Jung S, Schreiber H, Senel M, Vardakas I, Lulé DE,
et al. Sensitivity and Specificity of a Revised Version of the TRACK-MS Screening Battery for Early Detection of Cognitive Impairment in Patients with Multiple Sclerosis. Biomedicines. 2025; 13(8):1902.
https://doi.org/10.3390/biomedicines13081902
Chicago/Turabian Style
Balz, Luisa T., Ingo Uttner, Daniela Taranu, Deborah K. Erhart, Tanja Fangerau, Stefanie Jung, Herbert Schreiber, Makbule Senel, Ioannis Vardakas, Dorothée E. Lulé,
and et al. 2025. "Sensitivity and Specificity of a Revised Version of the TRACK-MS Screening Battery for Early Detection of Cognitive Impairment in Patients with Multiple Sclerosis" Biomedicines 13, no. 8: 1902.
https://doi.org/10.3390/biomedicines13081902
APA Style
Balz, L. T., Uttner, I., Taranu, D., Erhart, D. K., Fangerau, T., Jung, S., Schreiber, H., Senel, M., Vardakas, I., Lulé, D. E., & Tumani, H.
(2025). Sensitivity and Specificity of a Revised Version of the TRACK-MS Screening Battery for Early Detection of Cognitive Impairment in Patients with Multiple Sclerosis. Biomedicines, 13(8), 1902.
https://doi.org/10.3390/biomedicines13081902
